维普中文期刊产品整合服务

Low doses of ethanolic extract of Boldo(Peumus boldus) can ameliorate toxicity generated by cisplatin in normal liver cells of mice in vivo and in WRL-68 cells in vitro, but not in cancer cells in vivo or in vitro

查看全文 作  者:Jesmin [1]Mondal;Kausik [1]Bishayee;Ashis Kumar [2]Panigrahi;Anisur Rahman Khuda-[1]Bukhsh 高影响力作者 机构地区:[1]Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani;[2]Fisheries and Aquaculture Laboratory, Department of Zoology, University of Kalyani高影响力机构 出  处:《Journal of Integrative Medicine》索引2014年第12卷第5期,共14页高影响力期刊 基  金:supported by a grant of University of Grant Commission,New Delhi,India,sanctioned to Jesmin Mondal through Maulana Azad National Fellowship scheme 摘  要:OBJECTIVE: Use of cisplatin, a conventional anticancer drug, is restricted because it generates strong hepatotoxicity by accumulating in liver. Therefore its anticancer potential can only be fully exploited if its own toxicity is considerably reduced. Towards this goal, ethanolic extract of the plant, Boldo(Peumus boldus), known for its antihepatotoxic effects, was used simultaneously with cisplatin, to test its ability to reduce cisplatin's cytotoxicity without affecting its anticancer potential. METHODS: The cytotoxicity of Boldo extract(BE) and cisplatin, administered alone and in combination, was determined in three cancer cell lines(A549, HeLa, and HepG2) and in normal liver cells(WRL-68). Drug-DNA interaction, DNA damage, cell cycle, apoptosis, reactive oxygen species(ROS) and mitochondrial membrane potential(MMP, ΔΨ) were also studied. Hepatotoxicity and antioxidant activity levels were determined by alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase and glutathione assays in mice. The cytotoxicity of related proteins was tested by Western blotting. RESULTS: Co-administration of BE and cisplatin increased viability of normal cells, but had no effect on the viability of cancer cells. Boldo protected liver from damage and normalized different antioxidant enzyme levels in vivo and also reduced ROS and re-polarized MMP in vitro. Bax and cytochrome c translocation was reduced with caspase 3 down-regulation. Further, a drugDNA interaction study revealed that BE reduced cisplatin's DNA-binding capacity, resulting in a reduction in DNA damage. CONCLUSION: Results indicated that a low dose of BE could be used benefi cially in combination with cisplatin to reduce its toxicity without hampering cisplatin's anticancer effect. These fi ndings signify a potential future use of BE in cancer therapy. 关 键 词:乙醇提取物 肿瘤细胞 肝毒性 肝细胞 低剂量 顺铂 体外 体内
相关文献

参考文献(32)

引证文献(1)

耦合文献(169)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费